TiNivo  A Phase Ib Dose Escalation Trial of Tivozanib and Nivolumab in Renal Cell Carcinoma

TiNivo  A Phase Ib Dose Escalation Trial of Tivozanib and Nivolumab in Renal Cell Carcinoma

User Photo
kidneycancer

3 years
418 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Laurence Albiges, MD, PhD Institut Gustave Roussy Villejuif, France gives an overview of TiNivo  A Phase Ib Dose Escalation Trial of Tivozanib and Nivolumab in Renal Cell Carcinoma at the 2017 Kidney Cancer Association symposium in Miami, FL.

Up Next Autoplay
>